Ikarovec Seed
3 known investors
Ikarovec is a company focused on age-related macular degeneration (AMD), an eye condition that impairs central vision and can progress from Dry AMD to Wet AMD. It appears to work in the ophthalmology/eye disease space, addressing a condition projected to affect 288 million people by 2040.